Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia.
- Published in:
- Early Intervention in Psychiatry, 2019, v. 13, n. 3, p. 667, doi. 10.1111/eip.12685
- By:
- Publication type:
- Article
Works by Bell Lynum, Karimah S.
Results: 8
1
2
Aripiprazole Once-Monthly for the Treatment of Adult Patients in the Earlier Stages of Bipolar I Disorder: A Post Hoc Analysis of Clinical Trial Data.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
3
Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
- Published in:
- Current Medical Research & Opinion, 2022, v. 38, n. 6, p. 1019, doi. 10.1080/03007995.2022.2049162
- By:
- Publication type:
- Article
4
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 1409, doi. 10.2147/NDT.S412357
- By:
- Publication type:
- Article
5
Psychiatric Services: A Platform for MTM.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
6
A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2023, v. 13, n. 2, p. 1, doi. 10.1002/pul2.12237
- By:
- Publication type:
- Article
7
Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12134
- By:
- Publication type:
- Article
8
Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial.
- Published in:
- International Journal of Bipolar Disorders, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40345-024-00358-3
- By:
- Publication type:
- Article